|
|
|
|
|
Aim To assess the impact of poorly controlled asthma on overall healthcare by comparing resource use of those children less than 12 years who suffer attacks with those who do not. Method Two identical studies involved the audit of asthma management within a general practice setting. 393 practices from throughout the United Kingdom provided details of health service resource use over a retrospective 12 month period for 30 (minimum) patients randomly selected from the practice active asthma register. This provided a data set on the management of 2,770 patients under the age of 12 years (61% male) with asthma. All patients were invited for a clinical assessment. The database was utilised to determine whether usage of health service resource related to asthma control. Published unit cost data was then used to construct cost estimates for different management options. By pricing each individual item of resource use as in table 2, patient costs were calculated. The mean management costs, including confidence intervals, of patients who had experienced an asthma attack were compared with those who had not.
Conclusion The average annual cost of treating children with unstable asthma is £329.77 compared to £93.17 for those who are more controlled. 55% of the total cost was attributed to the 26% of children who experienced an asthma attack. 42% of this groups expenditure was due to hospital admission. The cost of emergency drugs used to treat attacks represented a negligible cost when compared with the cost of hospital stay. Treating more of the hospitalised children within general practice will greatly reduce costs. The high cost of managing children who have had an attack highlights the importance of prevention. Given the major burden associated with uncontrolled asthma, appropriate targeting of preventative measures and ensuring good compliance, could reduce overall healthcare costs and growing pressures on hospital services associated with management of asthma. This study was supported by a grant from Zeneca Pharmaceuticals. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
For further information on the Asthma Research Unit, please contact: Tayside Centre for General Practice University of Dundee Kirsty Semple Way Dundee DD2 4BF Scotland Tel : +44 (0)1382 420000 Fax :+44 (0)1382 420010 aru@tcgp.dundee.ac.uk |